Correction to: The role of fibrinolysis inhibition in engineered vascular networks derived from endothelial cells and adipose-derived stem cells

Severin Mühleder; Karoline Pill; Mira Schaupper; Krystyna Labuda; Eleni Priglinger; Pablo Hofbauer; Verena Charwat; Uwe Marx; Heinz Redl; Wolfgang Holnthoner

doi:10.1186/s13287-018-1001-3

Correction to: The role of fibrinolysis inhibition in engineered vascular networks derived from endothelial cells and adipose-derived stem cells

Stem Cell Res Ther. 2018 Oct 7;9(1):261. doi: 10.1186/s13287-018-1001-3.

Authors

Severin Mühleder^{1

2}, Karoline Pill^{1

2}, Mira Schaupper^{1

2

3}, Krystyna Labuda^{1

2}, Eleni Priglinger^{1

2}, Pablo Hofbauer⁴, Verena Charwat⁵, Uwe Marx⁶, Heinz Redl^{1

2}, Wolfgang Holnthoner^{7

8}

Affiliations

¹ Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, AUVA Research Centre, Donaueschingenstrasse 13, A-1200, Vienna, Austria.
² Austrian Cluster for Tissue Regeneration, Vienna, Austria.
³ Present address: Division of Plastic and Reconstructive Surgery, Department of Surgery, Medical University of Vienna, Vienna, Austria.
⁴ Institute of Molecular Biotechnology of the Austrian Academy of Science (IMBA), Vienna Biocenter (VBC), Vienna, Austria.
⁵ Department of Biotechnology, University of Natural Resources and Life Sciences (BOKU), Vienna, Austria.
⁶ TissUse GmbH, Berlin, Germany.
⁷ Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, AUVA Research Centre, Donaueschingenstrasse 13, A-1200, Vienna, Austria. wolfgang.holnthoner@trauma.lbg.ac.at.
⁸ Austrian Cluster for Tissue Regeneration, Vienna, Austria. wolfgang.holnthoner@trauma.lbg.ac.at.

Abstract

The original article [1] contains numerous value errors in the graphs in Fig. 2b regarding the markers describing the values for total tubule length and mean tubule length without aprotinin at 2.5 mg/ml concentration of fibrinogen. The corrected version of this figure can be viewed ahead.

Publication types

Published Erratum